Grantham, Mayo, Van Otterloo & Co (GMO)’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$377K Sell
1,784
-1,159
-39% -$250K ﹤0.01% 571
2025
Q4
$605K Buy
2,943
+1,410
+92% +$265K ﹤0.01% 568
2025
Q3
$241K Sell
1,533
-18,001
-92% -$2.78M ﹤0.01% 576
2025
Q2
$3.28M Buy
+19,534
New +$2.9M 0.01% 338
2022
Q1
Sell
-157,500
Closed -$8.11M 700
2021
Q4
$8.11M Sell
157,500
-38,300
-20% -$1.88M 0.04% 284
2021
Q3
$9.68M Buy
195,800
+137,816
+238% +$7.48M 0.05% 252
2021
Q2
$3.31M Buy
57,984
+9,244
+19% +$540K 0.02% 392
2021
Q1
$2.96M Buy
48,740
+32,100
+193% +$1.77M 0.02% 415
2020
Q4
$891K Buy
16,640
+5,400
+48% +$280K 0.01% 582
2020
Q3
$528K Buy
+11,240
New +$577K ﹤0.01% 618
2016
Q2
Sell
-4,800
Closed -$393K 574
2016
Q1
$393K Buy
+4,800
New +$390K ﹤0.01% 482
2015
Q2
Sell
-2,400
Closed -$217K 445
2015
Q1
$217K Buy
+2,400
New +$207K ﹤0.01% 425
2014
Q2
Sell
-56,000
Closed -$3.92M 505
2014
Q1
$3.92M Sell
56,000
-41,397
-43% -$2.88M 0.01% 330
2013
Q4
$6.51M Sell
97,397
-329,266
-77% -$20.1M 0.02% 263
2013
Q3
$22.3M Sell
426,663
-168,858
-28% -$8.58M 0.06% 133
2013
Q2
$28.1M Buy
+595,521
New +$27.2M 0.07% 106

Other funds holding CAH

Grantham, Mayo, Van Otterloo & Co (GMO)'s CAH Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Cardinal Health (CAH) stake by 39% in Q1 2026, selling an estimated $250K and leaving 1,784 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #571.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CAH in Q2 2013 and has held it in 16 quarters since. The position peaked at $28.1M in Q2 2013. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 1,784 shares of Cardinal Health worth $377K as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,159 Cardinal Health shares in Q1 2026, an estimated $250K.
  • Cardinal Health made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #571 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cardinal Health in Q2 2013 and has held it in 16 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Cardinal Health position peaked at $28.1M in Q2 2013.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.